Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001740053-20-000002
Filing Date
2020-02-14
Accepted
2020-02-14 11:21:13
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A chicagocapitaldyna13g.htm SC 13G/A 20640
  Complete submission text file 0001740053-20-000002.txt   22147
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-80035 | Film No.: 20615859
SIC: 2834 Pharmaceutical Preparations

Mailing Address 135 S LASALLE ST SUITE 3450 CHICAGO IL 60603
Business Address 135 S LASALLE ST SUITE 3450 CHICAGO IL 60603 3124292335
Chicago Capital, LLC (Filed by) CIK: 0001740053 (see all company filings)

EIN.: 823400556 | State of Incorp.: WA | Fiscal Year End: 1231
Type: SC 13G/A